Among the novel genetic alterations disclosed by whole genome/exome sequencing, NOTCH1, SF3B1 and BIRC3 lesions follows the same distribution across CLL clinical phases as TP53 and ATM abnormalities (Table 1). The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.